Xencor Inc (XNCR)

NASDAQ
27.12
+0.54(+2.03%)
After Hours
27.12
0.00(0.00%)
- Real-time Data
  • Volume:
    1,562,586
  • Day's Range:
    25.34 - 27.32
  • 52 wk Range:
    19.35 - 43.61

XNCR Overview

Prev. Close
26.58
Day's Range
25.34-27.32
Revenue
326.64M
Open
26.85
52 wk Range
19.35-43.61
EPS
1.76
Volume
1,562,586
Market Cap
1.61B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
353,203
P/E Ratio
15.39
Beta
0.69
1-Year Change
-25.29%
Shares Outstanding
59,542,935
Next Earnings Date
Aug 08, 2022
What is your sentiment on Xencor Inc?
or
Market is currently closed. Voting is open during market hours.

Xencor Inc Analysis

Xencor Inc Company Profile

Xencor Inc Company Profile

Employees
254

Xencor, Inc. is a clinical-stage biopharmaceutical company that is focused on discovering and developing engineered monoclonal antibodies and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The Company is advancing a portfolio of clinical-stage XmAb drug candidates from its protein engineering technology platforms. The Company uses its engineering capabilities to enable its understanding of protein structure and interactions to design technologies and XmAb development candidates with properties. It is focused on the Fc domain, which is the part of an antibody that interacts with various segments of the immune system and controls antibody structure. The Fc domain is constant and interchangeable among antibodies, and its engineered Fc domains are the XmAb technology, which can be readily substituted for natural Fc domains. Its drug candidates include Plamotamab, XmAb717, Tidutamab, XmAb841, XmAb306, AMG 509, XmAb819, XmAb104, XmAb564 and Novartis XmAb.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell